Teva Hit With Securities Class Action Over CEO Resignation

Teva Pharmaceutical Industries Inc. was slapped with a putative class action in New York federal court on Wednesday when a shareholder alleged the company intentionally misled the media and investors about a dispute between the CEO and the board of directors more

  • Tags: